Related Experiment Video
Updated: Jul 26, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
Ulcerative keratitis caused by beta-hemolytic Streptococcus equi in 11 horses
D.E. Brooks1, S.E. Andrew, D.J. Biros
1Departments of Large and Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, 32610, USA.
Beta-hemolytic Streptococcus equi causes aggressive ulcerative keratitis in horses, leading to severe corneal damage and potential vision loss. Prompt surgical and medical treatment is crucial for positive outcomes in equine eye infections.
Area of Science:
- Veterinary Ophthalmology
- Equine Infectious Diseases
- Microbiology
Background:
- Equine ulcerative keratitis is commonly associated with Gram-negative bacteria and fungi.
- Beta-hemolytic Streptococcus spp. are typically part of normal equine conjunctival flora but can cause severe infections.
Purpose of the Study:
- To document clinical cases of ulcerative keratitis in horses linked to beta-hemolytic Streptococcus equi.
- To analyze the clinical presentation, treatment, and outcomes of these specific equine eye infections.
Main Methods:
- Retrospective clinical study of 11 horses diagnosed with ulcerative keratitis.
- Bacteriological culture and antibiotic sensitivity testing of beta-hemolytic Streptococcus equi isolates.
- Review of clinical signs, treatment modalities, and patient outcomes.
Main Results:
- Beta-hemolytic Streptococcus equi (subspecies zooepidemicus in 10/11 cases) was identified as the causative agent.
- Severe keratomalacia, deep ulcers, descemetoceles, iris prolapse, and uveitis were common clinical signs.
- Treatment involved conjunctival flaps, corneal transplantation, and topical antibiotics; healing time averaged 44.7 days.
Conclusions:
- Beta-hemolytic Streptococcus spp. can cause severe, aggressive ulcerative keratitis in horses, distinct from typical equine ulcer pathogens.
- These bacteria demonstrate a capacity to degrade conjunctival graft tissue, complicating surgical management.
- Aggressive surgical intervention combined with intensive medical therapy, including topical antibiotics and protease inhibitors, is recommended.
More Related Videos
11:03Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy
Published on: January 22, 2018
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018